Charles Elliott Sigal Net Worth & Insider Trades

Charles Elliott Sigal - Director, Adaptimmune Therapeutics Plc

As of July 1, 2022

What is Charles Elliott Sigal's Net Worth?

The current estimated net worth of Adaptimmune Therapeutics Plc's Director, Charles Elliott Sigal, is estimated to be about $466.65K . Charles Elliott Sigal owns about 367,038 units of Adaptimmune Therapeutics Plc common stock. In the last 6 years at Adaptimmune Therapeutics Plc, Charles Elliott Sigal has sold an estimated value of $0 worth.

What is Charles Elliott Sigal's Past Insider Trading?

Charles Elliott Sigal's largest purchase order was 45,000 units , worth over $68.7K on May 18, 2016. In total, Charles Elliott Sigal has made about 9 transactions over 6 years of their time at Adaptimmune Therapeutics Plc. Charles Elliott Sigal usually trades in July, with the busiest year in 2016. The most recent transaction was a purchase order of 15,000 units , worth over $23.4K on May 19, 2016.

Charles Elliott Sigal

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Charles Elliott Sigal's' Mailing Address?

  • Mailing address is 32 Brearly Road Princeton NJ 08540 NJ

Adaptimmune Therapeutics Plc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Adrian Rawcliffe 2020 $574,000 $1,715,346 $378,840 $33,416 $2,701,602
Adrian Rawcliffe 2019 $500,481 $1,427,399 $177,251 $49,912 $2,155,042
Adrian Rawcliffe 2018 $457,011 $730,791 $174,807 $54,775 $1,417,384
Gavin Wood 2020 $337,065 $990,268 $166,847 $73,731 $1,567,911
Helen Tayton-Martin 2020 $454,940 $857,661 $225,195 $23,531 $1,561,327
Helen Tayton-Martin 2019 $435,949 $766,900 $137,324 $30,491 $1,370,664
Helen Tayton-Martin 2018 $408,308 $730,791 $156,178 $22,007 $1,317,284
William Bertrand 2020 $443,456 $857,661 $219,511 $30,485 $1,551,113
William Bertrand 2019 $432,640 $766,900 $136,282 $35,358 $1,371,180
William Bertrand 2018 $416,000 $685,114 $159,120 $35,070 $1,295,304
John Lunger 2020 $400,000 $857,661 $198,000 $31,802 $1,487,463
John Lunger 2019 $366,867 $435,546 $94,542 $35,655 $932,610
John Lunger 2018 $316,958 $602,909 $92,948 $35,07 $1,047,885
Michael Garone 2020 $217,000 - - - $217,000
Michael Garone 2019 $206,500 - - - $206,500
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1621227/000110465921047833/tm212433-2_def14a.htm

What are Adaptimmune Therapeutics Plc's Past Insider Trades?

Adaptimmune Therapeutics Plc's most recent insider trade came on January 17, 2023 by John Lunger who sold 4,440 units worth $8.25K . In the last 7 years, insiders at Adaptimmune Therapeutics Plc have sold an estimated value of $40.32M and bought an estimated value of $526.78M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Adrian Rawcliffe, Chief Executive Officer,  John Lunger, Chief Patient Supply Officer,  and William Charles Bertrand, Chief Operating Officer .

Adaptimmune Therapeutics PLC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1